Title | Type | SJR | H index | Total Docs. (2016) | Total Docs. (3years) | Total Refs. (2016) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2016) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Pharmacological Reviews | journal | 8.051 Q1 | 254 | 26 | 94 | 10565 | 1986 | 94 | 20.57 | 406.35 | |
2 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 0.706 Q2 | 82 | 14 | 45 | 2887 | 315 | 45 | 7.00 | 206.21 | |
3 | Pharmacology and Therapeutics | journal | 4.450 Q1 | 233 | 131 | 331 | 24955 | 4010 | 330 | 11.62 | 190.50 | |
4 | Medicinal Research Reviews | journal | 2.701 Q1 | 150 | 33 | 111 | 6234 | 1030 | 111 | 9.20 | 188.91 | |
5 | Drug Resistance Updates | journal | 3.794 Q1 | 132 | 31 | 41 | 5374 | 454 | 41 | 12.10 | 173.35 | |
6 | Reviews of Physiology Biochemistry and Pharmacology | journal | 2.844 Q1 | 70 | 11 | 19 | 1872 | 114 | 13 | 4.64 | 170.18 | |
7 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.236 Q3 | 29 | 6 | 30 | 995 | 46 | 0 | 1.44 | 165.83 | |
8 | Advances in Molecular Toxicology | book series | 0.129 Q4 | 18 | 9 | 22 | 1428 | 7 | 0 | 0.33 | 158.67 | |
9 | Advances in Pharmacology | journal | 1.526 Q1 | 86 | 39 | 119 | 5476 | 463 | 0 | 3.76 | 140.41 | |
10 | Perspectives in Medicinal Chemistry | journal | 2.425 Q1 | 17 | 2 | 8 | 277 | 83 | 8 | 10.38 | 138.50 | |
11 | Journal of Receptor, Ligand and Channel Research | journal | 0.196 Q4 | 13 | 1 | 16 | 137 | 7 | 16 | 0.50 | 137.00 | |
12 | Current Medicinal Chemistry | journal | 1.085 Q2 | 202 | 276 | 956 | 36282 | 3493 | 901 | 3.39 | 131.46 | |
13 | Current Pharmaceutical Design | journal | 1.069 Q2 | 183 | 581 | 1906 | 75638 | 5822 | 1740 | 2.73 | 130.19 | |
14 | Cellular and Molecular Life Sciences | journal | 3.259 Q1 | 261 | 305 | 919 | 38436 | 5674 | 909 | 6.22 | 126.02 | |
15 | Annual Review of Pharmacology and Toxicology | journal | 8.284 Q1 | 224 | 31 | 87 | 3850 | 1380 | 85 | 13.47 | 124.19 | |
16 | Current Drug Metabolism | journal | 0.881 Q2 | 122 | 86 | 242 | 10388 | 738 | 223 | 2.77 | 120.79 | |
17 | Progress in Medicinal Chemistry | journal | 1.714 Q1 | 38 | 6 | 17 | 656 | 73 | 0 | 5.36 | 109.33 | |
18 | Current Drug Targets | journal | 1.172 Q1 | 119 | 241 | 469 | 26140 | 1431 | 426 | 2.58 | 108.46 | |
19 | Current Neuropharmacology | journal | 1.385 Q1 | 103 | 120 | 169 | 12931 | 723 | 150 | 3.15 | 107.76 | |
20 | Expert Opinion on Therapeutic Targets | journal | 1.765 Q1 | 106 | 119 | 377 | 12656 | 1702 | 366 | 4.53 | 106.35 | |
21 | Neurotherapeutics | journal | 2.283 Q1 | 136 | 80 | 225 | 7887 | 1273 | 211 | 5.65 | 98.59 | |
22 | Current Psychopharmacology | journal | 0.109 Q4 | 4 | 16 | 4 | 1576 | 1 | 3 | 0.25 | 98.50 | |
23 | Current Molecular Pharmacology | journal | 1.090 Q2 | 49 | 37 | 73 | 3579 | 167 | 62 | 2.19 | 96.73 | |
24 | Vaccines | journal | 1.457 Q1 | 85 | 48 | 95 | 4565 | 385 | 92 | 4.08 | 95.10 | |
25 | Expert Opinion on Emerging Drugs | journal | 0.762 Q2 | 54 | 38 | 131 | 3609 | 377 | 127 | 3.21 | 94.97 | |
26 | Current Topics in Pharmacology | journal | 0.126 Q4 | 8 | 4 | 37 | 377 | 6 | 37 | 0.19 | 94.25 | |
27 | Mini-Reviews in Medicinal Chemistry | journal | 0.728 Q2 | 107 | 186 | 377 | 17338 | 1120 | 354 | 2.46 | 93.22 | |
28 | Progress in Neuro-Psychopharmacology and Biological Psychiatry | journal | 1.929 Q1 | 150 | 175 | 558 | 16223 | 2651 | 551 | 4.50 | 92.70 | |
29 | Current Cancer Drug Targets | journal | 1.271 Q1 | 103 | 84 | 221 | 7769 | 816 | 205 | 2.78 | 92.49 | |
30 | Current Pharmacology Reports | journal | 0.702 Q2 | 35 | 34 | 42 | 3104 | 102 | 42 | 2.43 | 91.29 | |
31 | Expert Opinion on Therapeutic Patents | journal | 1.057 Q2 | 88 | 110 | 328 | 9821 | 1305 | 325 | 3.16 | 89.28 | |
32 | Expert Opinion on Investigational Drugs | journal | 1.210 Q1 | 117 | 126 | 411 | 11124 | 1545 | 405 | 3.80 | 88.29 | |
33 | Trends in Pharmacological Sciences | journal | 5.350 Q1 | 244 | 97 | 267 | 8367 | 2852 | 211 | 11.06 | 86.26 | |
34 | CNS and Neurological Disorders - Drug Targets | journal | 1.003 Q2 | 96 | 144 | 500 | 12082 | 1247 | 440 | 2.47 | 83.90 | |
35 | Issues in Toxicology | book series | 0.110 Q4 | 18 | 76 | 133 | 6325 | 16 | 121 | 0.10 | 83.22 | |
36 | Expert Review of Precision Medicine and Drug Development | journal | 16 | 52 | 0 | 4245 | 0 | 0 | 0.00 | 81.63 | ||
37 | Expert Opinion on Biological Therapy | journal | 1.167 Q1 | 102 | 139 | 502 | 11318 | 1752 | 489 | 3.43 | 81.42 | |
38 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.928 Q2 | 100 | 138 | 403 | 11225 | 1389 | 399 | 3.40 | 81.34 | |
39 | Expert Review of Vaccines | journal | 1.482 Q1 | 105 | 141 | 416 | 11331 | 1366 | 386 | 3.31 | 80.36 | |
40 | Pharmacological Research | journal | 2.037 Q1 | 169 | 406 | 438 | 32415 | 2440 | 422 | 4.95 | 79.84 | |
41 | PharmaNutrition | journal | 0.613 Q3 | 30 | 18 | 72 | 1392 | 149 | 67 | 1.72 | 77.33 | |
42 | Journal of Pharmacy and Pharmaceutical Sciences | journal | 0.592 Q3 | 88 | 40 | 156 | 3079 | 363 | 155 | 1.73 | 76.98 | |
43 | Expert Opinion on Pharmacotherapy | journal | 1.014 Q2 | 93 | 238 | 734 | 17781 | 2325 | 715 | 3.40 | 74.71 | |
44 | Core Evidence (discontinued) | journal | 0.965 Q2 | 29 | 5 | 28 | 371 | 116 | 27 | 4.24 | 74.20 | |
45 | Pharmacognosy Reviews (discontinued) | journal | 1.140 Q1 | 68 | 20 | 68 | 1475 | 314 | 67 | 4.72 | 73.75 | |
46 | Drug Discovery Today | journal | 2.170 Q1 | 215 | 209 | 586 | 15377 | 3856 | 544 | 6.41 | 73.57 | |
47 | Chinese Herbal Medicines | journal | 18 | 1 | 0 | 73 | 0 | 0 | 0.00 | 73.00 | ||
48 | Neuropharmacology | journal | 2.355 Q1 | 191 | 433 | 1229 | 30501 | 6354 | 1206 | 5.25 | 70.44 | |
49 | British Journal of Pharmacology | journal | 2.670 Q1 | 244 | 257 | 1302 | 17373 | 7083 | 1276 | 5.52 | 67.60 | |
50 | Future Medicinal Chemistry | journal | 0.970 Q2 | 90 | 165 | 564 | 11139 | 1450 | 450 | 2.63 | 67.51 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®